Title of article
The clinical implications of endothelial dysfunction
Author/Authors
Michael E. Widlansky، نويسنده , , Noyan Gokce، نويسنده , , John F Keaney Jr، نويسنده , , Joseph A Vita، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2003
Pages
12
From page
1149
To page
1160
Abstract
Defining new approaches for the prevention and treatment of atherosclerosis is an important priority. Recently, measurement of endothelial function in patients has emerged as a useful tool for atherosclerosis research. Risk factors are associated with impaired endothelial function, and clinical syndromes relate, in part, to a loss of endothelial control of vascular homeostasis. Recent studies have shown that the severity of endothelial dysfunction relates to cardiovascular risk. A growing number of interventions known to reduce cardiovascular risk have been shown to improve endothelial function. This work suggests that studies of endothelial function could be used in the care of patients and as a surrogate marker for the evaluation of new therapeutic strategies. This article will review this growing literature in an effort to evaluate the current clinical utility of endothelial dysfunction.
Keywords
nitric oxide , BP , vascular cell adhesion molecule-1 , VCAM-1 , CAD , coronary artery disease , CVD , cardiovascular disease , ICAM , FMD , flow-mediated dilation , blood pressure , HRT , hormone replacement therapy , NO , intercellular adhesion molecule
Journal title
JACC (Journal of the American College of Cardiology)
Serial Year
2003
Journal title
JACC (Journal of the American College of Cardiology)
Record number
598297
Link To Document